I
Working Group Participants June 11–13, 1992

Claire Broome, M.D.

Associate Director for Science

Centers for Disease Control and Prevention

Atlanta, GA

Douglas L. Cocks, Ph.D.

Manager, Corporate Affairs

Eli Lilly

Indianapolis, IN

Ronald Ellis, Ph.D.

Executive Director

Virus and Cell Biology

Merck & Co., Inc.

West Point, PA

Peter Evans

World Health Organization

Geneva, Switzerland

Bernard Fritzell, Ph.D.

Director of Clinical Research

Connaught Laboratories, Inc.

Swiftwater, PA

Lance Gordon, Ph.D.

President and CEO

ORAVAX

Cambridge, MA

Carolyn Hardegree, M.D.

Director, Office of Biologics Research

U.S. Food & Drug Administration

Bethesda, MD

Akira Homma, M.D.

Regional Advisor in Biologics

Pan American Health Organization

Washington, DC



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 205
The Children's Vaccine Initiative: Achieving the Vision I Working Group Participants June 11–13, 1992 Claire Broome, M.D. Associate Director for Science Centers for Disease Control and Prevention Atlanta, GA Douglas L. Cocks, Ph.D. Manager, Corporate Affairs Eli Lilly Indianapolis, IN Ronald Ellis, Ph.D. Executive Director Virus and Cell Biology Merck & Co., Inc. West Point, PA Peter Evans World Health Organization Geneva, Switzerland Bernard Fritzell, Ph.D. Director of Clinical Research Connaught Laboratories, Inc. Swiftwater, PA Lance Gordon, Ph.D. President and CEO ORAVAX Cambridge, MA Carolyn Hardegree, M.D. Director, Office of Biologics Research U.S. Food & Drug Administration Bethesda, MD Akira Homma, M.D. Regional Advisor in Biologics Pan American Health Organization Washington, DC

OCR for page 205
The Children's Vaccine Initiative: Achieving the Vision Pamela Johnson, Ph.D. Chief, Applied Research Division Office of Health U.S. Agency for International Development Washington, D.C. Thomas D. Kiley, J.D. Attorney Hillsborough, CA Pierre Lemoine Chief, National Laboratory for Control of Vaccines Ministry of Public Health Brussels, Belgium David Lohr Vice President, Business Development Medisorb Technologies International, Ltd. Cincinnati, OH Richard Mahoney, Ph.D. Vice President and Director Technology Promotion Program for Appropriate Technology in Health Seattle, WA Harry M. Meyer, Jr., M.D. President, Medical Research Division American Cyanamid Co. Pearl River, NY David Mowery, Ph.D. Associate Professor University of California School of Business Berkeley, CA William Packer, C.P.A. President Virus Research Institute Cambridge, MA Timothy D. Proctor, J.D. Associate General Counsel Merck & Co., Inc. Rahway, NJ Philip K. Russell, M.D. Professor, Division of International Health John Hopkins School of Hygiene and Public Health Baltimore, MD Jerald C. Sadoff, M.D. Director Division of Communicable Diseases and Immunology Walter Reed Army Institute for Research Washington, DC Jay P. Sanford, M.D. Dean Emeritus Uniformed Services University of the Health Sciences Dallas, TX Donald Shepard, Ph.D. Professor Institute for Health Policy Brandeis University Waltham, MA Dale Spriggs, Ph.D.1 National Institute of Allergy and Infectious Diseases Bethesda, Maryland

OCR for page 205
The Children's Vaccine Initiative: Achieving the Vision Ann Wion, J.D. Associate Chief Counsel for Drugs and Biologics U.S. Food & Drug Administration Bethesda, MD WORKING GROUP PARTICIPANTS June 21–23, 1992 Frank Cano, Ph.D.2 Vice-President Lederle-Praxis Biologicals Pearl River, NY Mary Lou Clements, M.D. Professor and Head Division of Vaccine Sciences Johns Hopkins School of Hygiene and Public Health Baltimore, MD George Curlin, M.D. Deputy Director Division of Microbiology and Infectious Diseases National Institute for Allergy and Infectious Diseases Bethesda, MD Ciro de Quadros, M.D. Regional Advisor Expanded Program on Immunization Pan American Health Organization Washington, DC Michael Epstein, J.D. Partner Weil, Gotshal & Manges New York, NY Elaine Esber, M.D. Associate Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration Bethesda, MD Ronald W. Hansen, Ph.D. Associate Dean for Academic Affairs William E. Simon Graduate School of Business University of Rochester Rochester, NY Kerri-Ann Jones, Ph.D. Chief, Human Resources Development, Energy and Private Sector U.S. Agency for International Development Washington, DC David T. Karzon, M.D. Professor Vanderbilt University

OCR for page 205
The Children's Vaccine Initiative: Achieving the Vision School of Medicine Nashville, TN Scott Koenig MedImmune, Inc. Gaithersburg, MD David S. Krause, M.D. Director, Clinical Research, Development and Medical Affairs SmithKline Beecham King of Prussia, PA Wendy K. Mariner, J.D. Professor of Health Law Boston University School of Public Health Boston, MA Douglas Reynolds Vice President of Marketing Connaught Laboratories, Inc. Swiftwater, PA Bryan Roberts, Ph.D. Research Director Virus Research Institute Cambridge, MA Amy Scott Consumer Safety Officer U.S. Food & Drug Administration Bethesda, MD Jane Scott, Ph.D. Senior Director, Vaccine Development Lederle-Praxis Biologicals Pearl River, NY Seung-il Shin, Ph.D.3 Eugene Technologies International, Inc., Ramsey, NJ George Siber, M.D. Director, Biologic Laboratories Massachusetts Department of Public Health Jamaica Plain, MA Jane E. Sisk, Ph.D. Professor Columbia University School of Public Health New York, NY Thomas Stagnaro President and CEO UNIVAX Biologics Rockville, MD Richard I. Walker, Ph.D. Science Advisor National Vaccine Program National Institutes of Health Rockville, MD Michael White, M.D. Medical Officer Applied Research Division Office of Health U.S. Agency for International Development Washington, D.C. Douglas Williams Vice President, Marketing Connaught Laboratories, Inc. Swiftwater, PA

OCR for page 205
The Children's Vaccine Initiative: Achieving the Vision James F. Young, Ph.D. Vice President, Research & Development MedImmune, Inc. Gaithersburg, MD NOTES 1.   Dr. Spriggs is now with Virus Research Institute in Cambridge, MA. 2.   Dr. Cano is now President, Aviron, Belmont, Ca. 3.   Dr. Shin is now with the United Nations Development Program, New York, NY.